stella
beta
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis — Stella
Recruiting
Back to Systemic Lupus Erythematosus trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
The First Affiliated Hospital of Nanjing Medical University, Nanjing
View full record on ClinicalTrials.gov